Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Tetra Bio-Pharma

Health Canada Accepts New Drug Submission for REDUVO(TM) as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Accelerates PLENITUDE(C) Clinical Trial to Evaluate the Effect of Cannabis for Use in Managing Uncontrolled Cancer Pain
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Announces Start of the REBORN1(C) Clinical Trial
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures COVID-19 Cannabis Intellectual Property
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority
From Tetra Bio-Pharma
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial
From Tetra Bio-Pharma
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Announces Granting of U.S. Patent for Treatment of Interstitial Cystitis
From Tetra Bio-Pharma
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Tetra Bio-Pharma Provides Update on Its New Drug Submission Application in Canada
From Tetra Bio-Pharma
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers TBPMF TSX:TBP
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.